ATLASXOMICS INC
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.8Mattributed |
|---|---|
| Latest round | grant, $1.8M, 2023-09-01attributed |
| Founded | 2020 |
| Headquarters | NEW HAVEN, Connecticut, USA |
| Industry | bio |
| Stage | unknown |
| Website | atlasxomics.com |
Spatial epigenomics company commercializing the DBiT-seq platform for ATAC-seq, CUT&Tag, DNA methylation, and transcriptomics on tissue sections. Sold to 170+ research labs studying disease and developmental biology, including FFPE archive samples. Only spatial platform with multimodal epigenome readouts on the same section, paired with a code-free pipeline.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-09-01 | grant | $1.8M | undisclosed |
Detected tech stack
Afterpay, Linkedin Ads, Linkedin Insight Tag, Unpkg, Google Analytics, Google Tag Manager, Sentry, Spin.js, Squarespace, Squarespace Commerce, Stimulus, jQuery CDN
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.8M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.8M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | atlasxomics.com, read 2026-05-05 |
| Description | self-reported | atlasxomics.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.